Aripiprazole as an Inhibitor of the EGFR/PI3K/AKT Signaling Pathway and Sensitizer of MPA Suppressed Progestin‐Resistant Endometrial Cancer CellsWenqi Gan, Fei Mao|Archiv der Pharmazie|2025Cited by 1